ACIP Recommendations: Hepatitis B Vaccine

Published in Morbidity and Mortality Weekly Report (MMWR)

The Advisory Committee on Immunization Practices (ACIP) provides advice and guidance to the Director of the CDC regarding use of vaccines and related agents for control of vaccine-preventable diseases in the civilian population of the United States. Recommendations made by the ACIP are reviewed by the CDC Director and, if adopted, are published as official CDC/HHS recommendations in the Morbidity and Mortality Weekly Report (MMWR).

CURRENT Hepatitis B Vaccine Recommendations

• MMWR, April 1, 2022, Vol 71(13);477–483
  Universal Hepatitis B Vaccination in Adults Aged 19–59 Years: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022
  • Print version
• MMWR, April 20, 2018, Vol 67(15);455-458
  Recommendations of the Advisory Committee on Immunization Practices for Use of a Hepatitis B Vaccine with a Novel Adjuvant
  • Print version
• MMWR, January 12, 2018, Vol 67(RR-1);1-31
  Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices
  
  • Print version
• See also:
  • ACIP-VFC Resolution

ARCHIVED Hepatitis B Immunization Publications

For your convenience, these archived publications can be used for historical and research purposes.

• MMWR, December 23, 2011, Vol 60(50);1709-1711
  Use of Hepatitis B Vaccination for Adults with Diabetes Mellitus: Recommendations of the ACIP
  • Print version
  • GRADE Tables
• MMWR, October 12, 2007, Vol 56(40);1057
  Notice to Readers: FDA Approval of an Alternate Dosing Schedule for a Combined Hepatitis A and B Vaccine (Twinrix^®)
  • Print Version
• MMWR, December 8, 2006, Vol 55(RR-16);1-25
  A Comprehensive Immunization Strategy to Eliminate Transmission of Hepatitis B Virus Infection in the United States—Part 2: Immunization of Adults
  • Appendix A | Appendix B | Appendix C
  • Print version (includes appendices)
• MMWR, December 23, 2005, Vol 54(RR-16);1-23
  A Comprehensive Immunization Strategy to Eliminate Transmission of Hepatitis B Virus Infection in the United States—Part 1: Immunization of Infants, Children, and Adolescents
  • NOTE: If you are using the HTML versions of either of the last two recommendations, be sure to access all four links to get the complete content of the document, which includes 3 important appendices.
  • Appendix A | Appendix B | Appendix C
  • Print version (includes appendices)
• MMWR, Mar 14, 2003, Vol 52(10);203-204
  Notice to Readers: FDA Licensure of Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant), and Poliovirus Vaccine Combined, (PEDIARIX™) for Use in Infants
  • Print Version
• MMWR, Sep 21, 2001, Vol 50(37);806-7
  Notice to Readers: FDA Approval for a Combined Hepatitis A and B Vaccine
  • Print Version
• MMWR, Mar 31, 2000, Vol 49(12);261
  Notice to Readers: Alternate Two-Dose Hepatitis B Vaccination Schedule for Adolescents Aged 11-15 Years
  • Print Version
• See also:
  • MMWR, December 20, 2013, Vol 62(RR-10);1-19
    CDC Guidance for Evaluating Health-Care Personnel for Hepatitis B Virus Protection and for Administering Postexposure Management
    • Print version